OTCMKTS:LTUS Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free LTUS Stock Alerts $0.0050 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.0050▼$0.005050-Day Range$0.0040▼$0.007552-Week Range$0.0035▼$0.0120Volume39,766 shsAverage Volume16,357 shsMarket Capitalization$13.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Lotus Pharmaceuticals alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.Read More LTUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTUS Stock News HeadlinesApril 21, 2024 | msn.com73 Best TV Shows to Binge Watch (April 2024)April 18, 2024 | yahoo.comLotus’s New Electric SUV Is Coming This YearApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 16, 2024 | msn.comResearchers explore medicinal potential of lotus benzylisoquinoline alkaloidsApril 14, 2024 | au.news.yahoo.comModi promises India jobs, infrastructure if re-electedApril 14, 2024 | msn.comIndia's Modi promises jobs, infrastructure if BJP wins third termApril 12, 2024 | msn.comIs It a Miracle Drug or the Latest Showroom Sensation?April 12, 2024 | ca.finance.yahoo.comLotus Ventures Inc. (J.CN)April 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 10, 2024 | msn.comAnd Just Like That, Lotus Is an EV MakerApril 8, 2024 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionApril 6, 2024 | msn.comLong-standing vegan restaurant Blossoming Lotus closes after two decades in PortlandApril 4, 2024 | msn.comFentanyl kills thousands of Americans. Could plugging a gap in U.S. intelligence save lives?April 3, 2024 | finance.yahoo.comQ4 2023 NRX Pharmaceuticals Inc Earnings CallApril 3, 2024 | msn.comThis Swiss Car Company Built A Scuba-Diving Lotus Elise EVApril 2, 2024 | msn.comSteel Lotus Fitness to raise money for Harrisburg police K9March 29, 2024 | msn.com‘1923’ Breakout Brandon Sklenar To Co-Star Opposite Meghann Fahy In Christopher Landon’s ‘Drop’ From Platinum Dunes And BlumhouseMarch 24, 2024 | msn.com‘The White Lotus’ Thailand is next. These hotels do it on a budget.March 11, 2024 | msn.comLotus’s New Electric Flagship: The Emeya Hyper GT SedanMarch 8, 2024 | msn.comLotus Emira Finally Cleared For Sale In U.S. After Three YearsFebruary 26, 2024 | msn.comA former resident of The World cruise ship spent 6 years onboard, says it's not unlike 'The White Lotus'February 26, 2024 | msn.comEV maker Lotus Technology begins second week of trading after SPAC debutFebruary 26, 2024 | reuters.comChina securities regulator says penalties will be severe in market crackdownFebruary 19, 2024 | msn.comInternational Autism Conference scheduled for 27-30 April in Abu DhabiFebruary 19, 2024 | msn.comNRx Pharma Secures $5M Advance in Milestone Payment for Bipolar Depression DrugFebruary 18, 2024 | forbes.comThai Billionaire Dhanin To Merge Retail Businesses In $215 Million DealFebruary 15, 2024 | yahoo.comEverything to Know About 'The White Lotus' Season 3See More Headlines Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:LTUS CUSIPN/A CIKN/A Webwww.lotuspharma.com Phone(941) 267-9684Fax86-10-6389-9867Employees233Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,694,515,000Free FloatN/AMarket Cap$13.47 million OptionableNot Optionable Beta-0.42 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Zhong Yi Liu (Age 63)Founder, Chairman, Chief Executive Officer and President Comp: $180kMs. Yan Zeng (Age 55)Chief Financial Officer and Principal Accounting Officer Dr. Xing Shen (Age 53)Vice President of Corporate Development Key CompetitorsTonix PharmaceuticalsNASDAQ:TNXPImunonNASDAQ:IMNNMIRA PharmaceuticalsNASDAQ:MIRATraws PharmaNASDAQ:TRAWNanoViricidesNYSE:NNVCView All Competitors LTUS Stock Analysis - Frequently Asked Questions How have LTUS shares performed in 2024? Lotus Pharmaceuticals' stock was trading at $0.0043 at the beginning of 2024. Since then, LTUS shares have increased by 16.3% and is now trading at $0.0050. View the best growth stocks for 2024 here. How do I buy shares of Lotus Pharmaceuticals? Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LTUS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
